1-3 of 3
Joseph Saliba
Close
Sort by
Journal Articles

Germ-line JAK2 mutations in the kinase domain are responsible for hereditary thrombocytosis and are resistant to JAK2 and HSP90 inhibitors

Caroline Marty, Cécile Saint-Martin, Christian Pecquet, Sarah Grosjean, Joseph Saliba, Céline Mouton, Emilie Leroy, Ashot S. Harutyunyan, Jean-François Abgrall, Rémi Favier, Aurélie Toussaint, Eric Solary, Robert Kralovics, Stefan N. Constantinescu, Albert Najman, William Vainchenker, Isabelle Plo, Christine Bellanné-Chantelot
Journal: Blood
Blood (2014) 123 (9): 1372–1383.
https://doi.org/10.1182/blood-2013-05-504555
Published: 2014
Includes: Supplemental data
Journal Articles

Germline JAK2 Mutations In The Kinase Domain Are Responsible For Hereditary Thrombocytosis and Are Resistant To JAK2 and HSP90 Inhibitors

Caroline Marty, Ph.D, Cecile Saint-martin, Christian Pecquet, PhD, Sarah Grosjean, Joseph Saliba, PhD Student, Celine Mouton, Leroy Emilie, Ashot S. Harutyunyan, Jean-François Abgrall, Remy Favier, Eric Solary, Robert Kralovics, PhD, Stefan N. Constantinescu, MD, PhD, Albert Najman, MD, William Vainchenker, MD, PhD, Isabelle Plo, Ph.D, Christine Bellanné-Chantelot
Journal: Blood
Blood (2013) 122 (21): 1603.
https://doi.org/10.1182/blood.V122.21.1603.1603
Published: 2013
Journal Articles

Modeling JAK2 V617F Heterozygous and Homozygous Mutations by Using Induced Pluripotent Stem Cells Derived From Myeloproliferative Neoplasms Patients

Joseph Saliba, PhD Student, Sofiane Hamidi, PhD Student, Antonio Di Stefano, PhD, Thierry Langlois, Gaëlle Lenglet, PhD, Lise Secardin, Anne Galy, PharmD, PhD, Paule Opolon, Najet Debili, PhD, Hana Raslova, PhD, Françoise Norol, Isabelle Plo, Ph.D, William Vainchenker, MD, PhD
Journal: Blood
Blood (2012) 120 (21): 1758.
https://doi.org/10.1182/blood.V120.21.1758.1758
Published: 2012